FDA conducts inspection of Fong Kee Tofu Company, Inc. in San Francisco on May 15, 2024

Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA
Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA - Official Website
0Comments

The Food and Drug Administration carried out an inspection of Fong Kee Tofu Company, Inc., located in San Francisco, on May 15, 2024, according to data posted on the FDA’s website.

The FDA’s final report recommended that Fong Kee Tofu Company, Inc. address issues related to managing operations concerning foodborne biological hazards. No corrective action was deemed necessary for other inspected areas.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Todd M. Lyons, Acting Director, U.S. Immigration And Customs Enforcement

ICE confirms suspect in San Francisco stabbing is Venezuelan national released under federal policy

ICE identified Wilfredo Jose Tortolero-Arriechi as a Venezuelan national suspected in a fatal stabbing at Zuckerberg San Francisco General Hospital. Officials say he entered the U.S. illegally in 2023 before being released under federal policy.

Dr. Mehmet Oz CMS Administrator

San Francisco Medicaid spending on evaluation and management services climbs to $58.99 million in 2024

Medicaid payments for Evaluation and Management services rose 15.8% in San Francisco in 2024, highlighting changes in how these services are utilized and reimbursed.

Dr. Mehmet Oz CMS Administrator

Medicaid spending on medicine services and procedures climbs 22.6% in San Francisco for 2024

In 2024, Medicaid providers in San Francisco billed $67,599,702 for Medicine Services and Procedures, reflecting a 22.6% increase compared to the prior year.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from San Francisco Sun.